Dentists in Chatsworth, CA Accepting Medicare

29 Dentists found. Showing 21 - 29

Dr. James A Pasternak, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 21000 Devonshire St, Ste 209, Chatsworth, CA 91311 Phone: 818-998-1851    Fax: 818-998-1878

Milad Zadfar, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 9929 Topanga Canyon Blvd, Chatsworth, CA 91311 Phone: 818-818-5123

Dr. Alan Richard Wolfson, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 21029 Devonshire St, Chatsworth, CA 91311 Phone: 818-998-6446

Dr. Michael Anthony D'egidio, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 21029 Devonshire St, Chatsworth, CA 91311 Phone: 818-998-6446

Martha Pleitez, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 10244 Canoga Ave Ste 2, Chatsworth, CA 91311 Phone: 818-718-8433

Dr. Matt Dale Maclean, D.M.D.,M.S. Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 10234 Canoga Ave, Chatsworth, CA 91311 Phone: 818-341-5150    Fax: 818-341-0123

Dr. Jonathan M Florendo, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 9800 Topanga Canyon Blvd, Suite J, Chatsworth, CA 91311 Phone: 818-576-0600

Mr. Bernardino B Villadiego, D.D.S Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 20933 Devonshire St, Suite 103, Chatsworth, CA 91311 Phone: 818-341-1345    Fax: 818-341-6427

Dr. David Jeffrey Rudolph, DDS MS PHD Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 9453 Gierson Ave, Chatsworth, CA 91311 Phone: 818-718-1737    Fax: 818-718-1735

News Archive

BrainStorm Cell Therapeutics reports financial results for Q1 2015, provides business update

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced financial results and provided a business update for the first quarter ended March 31, 2015.

European Commission approves MICARDIS medication for CV protection

MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.

NWBT receives $490,000 in two grants under QTDP program

Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.

Chronic kidney disease of undetermined causes could be common in tropical and subtropical rural settings

Chronic kidney disease of undetermined causes, initially reported among agricultural communities in Central America and Sri Lanka, is also present in India, particularly in Southern rural areas, and could be common in other tropical and subtropical rural settings.

Read more Medical News

› Verified 7 days ago

• 1
• 2(current)